LAZARD ASSET MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 234 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$93
-26.8%
8,589
+25.8%
0.00%
Q1 2024$127
-100.0%
6,825
-75.0%
0.00%
-100.0%
Q3 2021$1,208,000
+1758.5%
27,292
+3033.4%
0.00%
Q1 2021$65,000
-35.6%
871
-47.5%
0.00%
Q3 2020$101,000
-70.1%
1,658
-79.7%
0.00%
-100.0%
Q2 2020$338,000
+724.4%
8,151
+462.1%
0.00%
Q1 2020$41,000
-95.9%
1,450
-73.1%
0.00%
-100.0%
Q2 2019$988,000
+15.2%
5,4000.0%0.00%
+100.0%
Q1 2019$858,000
+66.0%
5,4000.0%0.00%0.0%
Q4 2018$517,000
-32.2%
5,4000.0%0.00%0.0%
Q3 2018$762,000
-59.5%
5,400
-55.1%
0.00%
-66.7%
Q2 2018$1,882,000
+116.6%
12,029
+122.8%
0.00%
+200.0%
Q1 2018$869,000
-41.6%
5,400
-40.3%
0.00%
-66.7%
Q4 2017$1,488,000
+50.3%
9,045
-43.1%
0.00%
+50.0%
Q3 2017$990,000
-51.2%
15,900
-37.6%
0.00%
-50.0%
Q2 2017$2,030,000
+8.2%
25,500
-3.4%
0.00%0.0%
Q1 2017$1,876,000
-35.9%
26,400
-53.9%
0.00%
-33.3%
Q4 2016$2,925,000
-22.1%
57,300
-29.8%
0.01%
-14.3%
Q3 2016$3,757,000
+117.7%
81,600
+42.4%
0.01%
+75.0%
Q2 2016$1,726,000
-6.0%
57,3000.0%0.00%0.0%
Q1 2016$1,837,000
-45.0%
57,3000.0%0.00%
-50.0%
Q4 2015$3,340,000
+26.5%
57,300
-8.2%
0.01%
+33.3%
Q3 2015$2,641,000
-43.2%
62,425
-2.0%
0.01%
-40.0%
Q2 2015$4,650,00063,7000.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders